Bruce J. Barclay served as the CEO of SurModics, Inc. from July 2005 until December 2010. He has a solid background in the healthcare industry, holding a B.S. in chemistry and a B.A. in biology from Purdue University, along with...
Bruce J. Barclay served as the CEO of SurModics, Inc. from July 2005 until December 2010. He has a solid background in the healthcare industry, holding a B.S. in chemistry and a B.A. in biology from Purdue University, along with a J.D. from the Indiana University School of Law. Before leading SurModics, he was the President and CEO of Vascular Architects, and he had significant roles at Guidant Corporation where he was involved in key developments in the interventional cardiology field. He even worked at Eli Lilly, which is a big name in pharmaceuticals. During his time at SurModics, his pay fluctuated, showing the challenges of aligning executive compensation with company performance. For instance, in 2009, he earned about $1,034,900 while in 2010, the compensation dropped to $623,150, reflecting unmet corporate performance targets. He left behind a legacy of navigating SurModics through a tough market as its stock saw ups and downs, reminding everyone that running a healthcare company is not just about the numbers but also about innovation and competition.